Suven Life finalizes phase I trial for Alzheimer drug

Suven Life finished phase I clinical trial of Suvn-502, a new chemical unit for Alzheimer’s disease cure, and told that it is submitting files for Investigational New Drug application with the US Food and Drug Administration.

0 comments: